Iwata Tomonori
Department of Stroke Treatment, Shonan Kamakura General Hospital Stroke Center.
Rinsho Shinkeigaku. 2014;54(12):1200-2. doi: 10.5692/clinicalneurol.54.1200.
Recently, remarkable progress has been made in the field of endovascular treatment, and endovascular treatment for acute ischemic stroke due to large vessel occlusion has been an effective and therapeutic option. However, there is no randomized control trial as to superiority of endovascular treatment for acute ischemic stroke compared to the standard treatment including intravenous rt-PA. Inclusion criteria for the performance of endovascular treatment for acute ischemic stroke will need to be defined more precisely, and high rates of fast recanalization will be needed in future. We expect the evidence that endovascular treatment for acute ischemic stroke due to large vessel occlusion is superior to standard treatment by the detailed images of the brain, more strict indications and novel endovascular devices such as percutaneous transluminal mechanical thrombectomy devices.
近年来,血管内治疗领域取得了显著进展,大血管闭塞所致急性缺血性卒中的血管内治疗已成为一种有效的治疗选择。然而,与包括静脉注射rt-PA在内的标准治疗相比,关于急性缺血性卒中血管内治疗优越性的随机对照试验尚无定论。急性缺血性卒中血管内治疗的纳入标准需要更精确地界定,未来还需要高比例的快速再通。我们期待通过详细的脑部影像、更严格的适应证以及新型血管内装置(如经皮腔内机械取栓装置)来证明大血管闭塞所致急性缺血性卒中的血管内治疗优于标准治疗。